Psychedelics for Trauma, Shame, and Dissociation: Uncover, Discover, Connect, and Heal

Abstract
This event contains a series of four brief presentations followed by an audience-interactive forum discussion. At the outset, to familiarize attendees with the history of cultural and legal changes that have, alternately, stymied and accelerated progress toward integrating psychedelic medicine into psychotherapeutic treatment, Jon Cleveland will orient attendees to some of the major developments in the use of psychedelic drugs for treating mental illness in this country occurring over the past seven decades. Next, CJ Healy will present data from two original studies regarding the use of psychedelics with therapeutic intent in naturalistic settings by adults with histories of child maltreatment. Results regarding the impact of such psychedelic use on complex trauma symptoms and internalized shame as well as regarding psychological mechanisms of therapeutic action will be discussed. A theoretical model of the therapeutic action of psychedelic experiences in the treatment of complex trauma will also be discussed. A third brief presentation, by Jon Cleveland, will address hallucinogen persisting perception disorder (HPPD), a heretofore poorly understood condition. His recent research indicates a link to developmental trauma and later dissociation. He will also share clinical observations that suggest that some symptoms of HPPD may respond to established psychosensory trauma treatment approaches. In the fourth brief presentation, Norman Alessi will discuss his clinical experience running a ketamine treatment center where a variety of conditions, including PTSD and dissociative disorders, are treated. Ketamine is the only legal "psychedelic" increasingly accepted as a medication for the treatment of depression, PTSD, anxiety and other clinical conditions. Unique among its properties is it being regarded as a dissociative agent. If so, can it be used to treat dissociative disorders? Are its psychedelic properties helpful in their treatment? A case series of patients with dissociative conditions will be reviewed to explore these issues. The event will culminate in an audience-interactive discussion concerning the current state and future of psychedelic medicine in the realm of complex trauma and dissociation.

 

Potential to Distress: No

This recorded conference session was originally presented as part of a live conference in April 2024.

Target Audience

Those seeking to participate in this webinar must be licensed mental health professionals (psychiatrists, psychologists, clinical social workers, mental health counselors, accredited psychotherapists, etc.). ISSTD staff will audit license information prior to the start of the course and may request additional documentation for your license.

We do accept students enrolled in a program of study leading to a degree or certification in the mental health field and who have an interest in trauma and dissociation. Students must submit proof of student status such as a transcript or registration record. For those who have completed their degree and are currently in the pre-licensure stage practicing under the license of another clinician, you must provide the name and license information for the person you are working with. Documentation should be sent to ISSTD staff at [email protected] before registering. 

This webinar content is at the beginning/introductory level.

Learning Objectives

Learning Objectives

  1. Learners will be able to identify key historical developments spanning the past 70 years of psychedelic-assisted psychotherapy research.

  2. Learners will be able to discuss and compare the potential therapeutic benefits and risks of psychedelic experiences in clinical and naturalistic settings by people with histories of complex trauma.

  3. Learners will be able to describe the relationship between trauma, dissociation, and hallucinogen-persisting perception disorder (HPPD).

  4. Learners will be able to identify the qualities of psychotherapeutic relationships and settings that facilitate improved outcomes during psychedelic-assisted psychotherapy.

  5. Learners will be able to discuss and compare the potential therapeutic benefits, shortcomings and risks of ketamine in the treatment of dissociative conditions and complex childhood trauma.

Course summary

Available credit: 
  • 1.50 APA
    The International Society for the Study of Trauma and Dissociation is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Society for the Study of Trauma and Dissociation maintains responsibility for this program and its content.
  • 1.50 ASWB ACE
    The International Society for the Study of Trauma and Dissociation (ISSTD), #1744, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 08/20/2024 – 08/20/2027. Social workers completing this course receive 1.50 continuing education credits.
  • 1.50 ISSTD Certificate Program
    This program is eligible for 1.50 credits in the ISSTD Certificate Program. No certificate of completion is generated for this type of credit.
Course opens: 
01/21/2025
Course expires: 
12/31/2050
ISSTD Member cost:
$35.00
Your Price:
$55.00
Rating: 
0

Jonathan Cleveland, Ph.D.
Jonathan M. Cleveland, Ph.D. is the director of adult psychology and director of training at a group practice in Southwestern Ohio. He is also a member of the clinical faculty at Wright State University’s School of Professional Psychology. Over the past decade, he has developed a clinical training program where doctoral students and postdoctoral residents learn to work with complex trauma and dissociation. Jon’s published research has focused on the relationship between hypnosis and dissociation, as well as the impact of childhood disclosure of sexual abuse on adult functioning. More recently, he has initiated a research project investigating the role of early adversity, trauma and dissociation in the etiology and maintenance of hallucinogen-persisting perception disorder (HPPD). He has presented on these topics at national and international conferences over the past few years. Jon is past editor of Trauma Psychology News. His clinical approach is psychodynamic, incorporating hypnosis, ego state therapy, havening, and EMDR. Over the course of treatment, he collaborates with his clients to boost insight, self-esteem, resiliency, flexibility, the ability to trust, as well as the capacity for humor and creative expression. Having served on the ISSTD board of directors since 2022, Jon is the current vice president of the organization (2025-2027). He is co-chair of the annual awards committee, chair of the research special interest group, and chair of the Midwest regional online community. He also serves on the science and membership committees. In his leisure time, Jon finds himself cooking, reading, and tinkering with synthesizers. He also enjoys playing golf and traveling to new places to ski & scuba dive with friends.

Norman Alessi, M.D., DLFAPA, LFAACAP
Norman Alessi is a Professor Emeritus, University of Michigan School of Medicine, Department of Psychiatry, whose earlier academic interests focused on the identification of mood disorders in children and adolescents and their treatment using psychopharmacological agents. Later areas have included ASD, juvenile offenders, aggression and most recently the use of ketamine in the treatment of psychiatric conditions and how it affects clinical symptoms of several conditions. Conditions of interest include dissociative disorders, dissociative identity disorder, and complex childhood trauma. He has developed a clinic that allows him to administer ketamine via a number of different routes including infusion and be present throughout the procedure. Participating in over 150 sessions, he has come to better understand the medication and what really happens rather than just seeing patients hours after the administration of the medication. Dr. Alessi is board certified in general psychiatry and child and adolescent psychiatry with 40 years of active clinical practice. He has authored 85 peer reviewed articles; 18 book chapters; 61 scientific abstracts; and, 179 presentations, posters, and panel discussions. He also has extensive administrative experience in departmental, institutional, state and national committees. He is founder and CEO of the Alessi Psychiatry and Life Center, located in Ann Arbor, MI.

CJ Healy, M.A. (they/them/theirs)
CJ Healy, M.A. is a fourth-year doctoral student in the Clinical Psychology Ph.D. program at the New School for Social Research in New York. They are a member of the Trauma and Affective Psychophysiology Lab under the mentorship of Wendy D'Andrea, Ph.D. Their research focuses on elaborating the psychological, behavioral, and physiological mechanisms of therapeutic action of psychedelics when used in naturalistic, ceremonial, or clinical settings, particularly with respect to their potential utility in the treatment of developmental trauma. They draw on the theoretical frameworks of contemporary psychoanalysis and interpersonal neurobiology in order to approach an integrative understanding of symptom reduction and character change associated with psychedelic experiences. They are a member of the Trainee Editorial Board of Psychedelic Medicine under co-editors-in-chief Peter Hendricks, Ph.D. and Charles Nichols, Ph.D. and the student coordinator of the Sándor Ferenczi Center under co-directors Adrienne Harris, Ph.D. and Miriam Steele, Ph.D. They were a 2022 recipient of a Source Award from the Source Research Foundation. They were also a recipient of a Fellowship from the Columbia University Center for Psychoanalytic Training and Research in 2021-2022 and of a Scholars Award from the Sexualities and Gender Identities Committee of the Society for Psychoanalysis and Psychoanalytic Psychology (APA Division 39) in 2023-2024. They have an M.A. in General Psychology from the New School for Social Research and a B.A. in Plan II Honors, African and African Diaspora Studies, and History from the University of Texas at Austin, where they were a member of the inaugural class of the Texas Exes Forty Acres Scholars Program, the university's premier full-ride, merit-based scholarship.

Available Credit

  • 1.50 APA
    The International Society for the Study of Trauma and Dissociation is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Society for the Study of Trauma and Dissociation maintains responsibility for this program and its content.
  • 1.50 ASWB ACE
    The International Society for the Study of Trauma and Dissociation (ISSTD), #1744, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 08/20/2024 – 08/20/2027. Social workers completing this course receive 1.50 continuing education credits.
  • 1.50 ISSTD Certificate Program
    This program is eligible for 1.50 credits in the ISSTD Certificate Program. No certificate of completion is generated for this type of credit.

Price

ISSTD Member cost:
$35.00
Your Price:
$55.00
Please login or register to take this course.

"Your Price" above reflects your final price based on your membership status and career level. 

  • ISSTD defines a student as those enrolled in a program of study leading to a degree or certification in the mental health field and who have an interest in trauma and dissociation. 
  • ISSTD defines an emerging professional as mental health professionals who have completed an advanced degree and are in the first three years of their career (or first three years after graduation for researchers).
  • If you do not fall into one of the above categories please register as Professional/Retired. 

These prices are for Tier I countries. For a list of countries by Tier click here. If you are located in a country that falls into Tier II-VI please contact ISSTD at [email protected] to receive the appropriate discount code.

Registration Policies

All purchases of recorded content are final.

For additional webinar policies including completion requirements, filing grievances, requesting a disability accommodation, and awarding of certificates of credits, please visit our Policies page.